Sort   by:  
 Page size 
UnknownAllogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
Not available
S-EPMC4872017 | biostudies-literature
UnknownFine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Not available
S-EPMC4406292 | biostudies-literature
UnknownFunctional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
Not available
S-EPMC3617380 | biostudies-literature
UnknownFine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Not available
S-EPMC4289692 | biostudies-literature
UnknownIdentification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Not available
S-EPMC4334820 | biostudies-literature
UnknownLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.
Not available
S-EPMC3771688 | biostudies-literature
UnknownGenome-wide association studies identify four ER negative-specific breast cancer risk loci.
Not available
S-EPMC3771695 | biostudies-literature
UnknownCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
Not available
S-EPMC4204770 | biostudies-literature
UnknownNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206 | biostudies-literature
UnknownGenome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Not available
S-EPMC4549775 | biostudies-literature
Sort   by:  
 Page size